Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

New algorithm aims to end the pain of multiple needle sticks

NCT ID NCT05935228

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now This study
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study tests a new decision-making tool that helps nurses assess how hard it will be to place an IV line. The tool scores patients based on vein visibility, size, and past difficulties, then suggests the best approach. Researchers hope this will reduce the number of needle sticks, pain, and complications for the 1 in 4 patients with difficult veins. The pilot will involve 794 adults in France and gather feedback from healthcare workers.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
A-DIVA Scale and algorithm (decision-making tool)
What this could lead to
If successful, this algorithm could help nurses place IV lines on the first try more often, reducing pain, bruising, and infections for patients with hard-to-find veins.
What could go wrong
This is a pilot study, so it is small and early. The algorithm may not improve outcomes in real-world settings, and results may not apply to all hospitals or patient groups.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

About 794 people

The number the study aims to enrol. It can still change while the study runs.

Started

Dec 2023

Expected to finish

Jun 2027

An estimate. End dates often move.

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

18 years and older

Sex

Anyone

Healthy volunteers

Accepted

You do not need to have the condition being studied to take part.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Patient inclusion criteria: adult patients, initially requiring at least one peripheral venous catheter (PVC), having given their consent for the study. * Inclusion criteria for healthcare professionals: Nurses, specialized nurses (IADE) and physicians attached to the department. Exclusion Criteria: Patient exclusion criteria : * Minor patients * Patients under curators or guardianship * Patients who are non-communicative or unable to give consent * Patients not requiring a peripheral venous catheter, polytrauma patients and patients in shock (septic, hemorrhagic, cardiogenic, spinal, specific to certain centers and equipped upstream) * Patients who already have catheters on arrival. Exclusion criteria for healthcare professionals: any professional not attached to the department and other professional categories.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Peripheral venous access are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

How to take part

Only the study team decides who joins. These are the ways to reach them.

  1. The places running it

    1 site. The list below names each one and where it is.

  2. The official record

    ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.

    Open the record ↗

  3. A doctor treating you

    A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.

Contacts and locations

Locations

  • Center Hospital Nancy

    RECRUITING

    Vandœuvre-lès-Nancy, 54 500, France